GIST experts provided updates and answered questions on GIST research and new GIST therapies.
During this webcast presentation, Dr. Michael Heinrich will discuss these two new treatment options for advanced GIST. Dr. Heinrich will explain how each of these drugs works to target mutations for which there has previously been no targeted treatment and discuss the current coronavirus outbreak.
LRG members Jennifer & Owen Moore give their perspective on participating in the Phase I BLU-285 trial at OSHU with Dr. Michael Heinrich. After three other drug treatment lines and faced with several growing tumors, the BLU-285 (avapritinib) trial was Owen’s best option.
The Life Raft Group Clinic Trials Database currently lists 31 trials that are open that are or could be of interest to GIST patients. Many of the most interesting of these new drugs are [...]
The Life Raft Group and UCSD hosted a three-day event at University of California, San Diego UCSD-Moores Cancer Center from July 13th through July 15th. A GIST Awareness Day (GAD) event took place on July [...]
It's not too late to sign up for the GIST Day of Learning (GDOL) in La Jolla/San Diego on July 15th. We are very excited to have some of the top GIST experts present [...]
A significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, [...]
GDOLs are free, one-day programs that provide both education and support for the GIST community. Top GIST specialists present the latest on research and treatment options and provide a comprehensive review of the [...]
The Life Raft Group kicked off its 2016 GIST Day of Learning (GDOL) series this spring with events from coast to coast. GDOLs are free, one-day programs that provide both education and support for the GIST [...]
On Sunday, November 15, the last GDOL in the 2015 series was held in Orange County, California at the Fullerton Arboretum. GDOL stands for GIST Day of Learning, a free, one-day program that [...]